The study to access the efficacy of tranexamic acid during excisional burn surgery (TRANEX)

illustrative image

The research company Maasstad Hospital is conducting the clinical trial Tranexamic Acid During Excisional Burn Surgery (TRANEX).

The purpose of this study is to access the efficacy of the drug tranexamic acid in reducing blood loss during burn excision surgery.

It is planned to include 96 participants.

Further details can be found here: https://ichgcp.net/clinical-trials-registry/NCT05507983.

Clinical Research News

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma

Upcoming Clinical Trials

The study to access the efficacy of tranexamic acid during excisional burn surgery (TRANEX)

All jobs

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe